Clinical Trial - Trial jRCT1041230013
Access comprehensive clinical trial information for jRCT1041230013 through Pure Global AI's free database. This phase not specified trial is sponsored by sponsor not specified and is currently Recruiting. The study focuses on Hepatocellular carcinoma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
jRCT1041230013
Recruiting
Trial Details
Japan Registry Clinical Trial • jRCT1041230013
Untitled Trial
Phase II study of preceding local therapy to Single Tremelimumab Regular Interval Durvalumab for patients with hepatocellular carcinoma treated with systemic chemotherapy
Study Focus
Interventional
Sponsor & Location
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Malignant neoplasm: Hepatoblastoma
Malignant neoplasm: Liver cell carcinoma
Malignant neoplasm: Other specified carcinomas of liver
Malignant neoplasm: Liver, unspecified
Malignant neoplasm: Hepatic flexure
Data Source
Japan Registry Clinical Trial
jRCT1041230013
Non-Device Trial